BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38005931)

  • 21. Development and use of SIV-based Integrase defective lentiviral vector for immunization.
    Michelini Z; Negri DR; Baroncelli S; Spada M; Leone P; Bona R; Klotman ME; Cara A
    Vaccine; 2009 Jul; 27(34):4622-9. PubMed ID: 19523909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo.
    Philippe S; Sarkis C; Barkats M; Mammeri H; Ladroue C; Petit C; Mallet J; Serguera C
    Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17684-9. PubMed ID: 17095605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel integrase-defective lentiviral episomal vectors for gene transfer.
    Vargas J; Gusella GL; Najfeld V; Klotman ME; Cara A
    Hum Gene Ther; 2004 Apr; 15(4):361-72. PubMed ID: 15053861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lentiviral Vectors Mediate Long-Term and High Efficiency Transgene Expression in HEK 293T cells.
    Mao Y; Yan R; Li A; Zhang Y; Li J; Du H; Chen B; Wei W; Zhang Y; Sumners C; Zheng H; Li H
    Int J Med Sci; 2015; 12(5):407-15. PubMed ID: 26005375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of a self-inactivating lentiviral vector expressing simian immunodeficiency virus gag for induction of specific immune responses in vitro and in vivo.
    Buffa V; Negri DR; Leone P; Borghi M; Bona R; Michelini Z; Compagnoni D; Sgadari C; Ensoli B; Cara A
    Viral Immunol; 2006; 19(4):690-701. PubMed ID: 17201664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficient gene transfer to human peripheral blood monocyte-derived dendritic cells using human immunodeficiency virus type 1-based lentiviral vectors.
    Chinnasamy N; Chinnasamy D; Toso JF; Lapointe R; Candotti F; Morgan RA; Hwu P
    Hum Gene Ther; 2000 Sep; 11(13):1901-9. PubMed ID: 10986562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lentivirus-mediated gene transfer and expression in established human tumor antigen-specific cytotoxic T cells and primary unstimulated T cells.
    Zhou X; Cui Y; Huang X; Yu Z; Thomas AM; Ye Z; Pardoll DM; Jaffee EM; Cheng L
    Hum Gene Ther; 2003 Jul; 14(11):1089-105. PubMed ID: 12885348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving the Transduction of Bone Marrow-Derived Cells with an Integrase-Defective Lentiviral Vector.
    Pay SL; Qi X; Willard JF; Godoy J; Sankhavaram K; Horton R; Mitter SK; Quigley JL; Chang LJ; Grant MB; Boulton ME
    Hum Gene Ther Methods; 2018 Feb; 29(1):44-59. PubMed ID: 29160102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skeletal Muscle Is an Antigen Reservoir in Integrase-Defective Lentiviral Vector-Induced Long-Term Immunity.
    Lin YY; Belle I; Blasi M; Huang MN; Buckley AF; Rountree W; Klotman ME; Cara A; Negri D
    Mol Ther Methods Clin Dev; 2020 Jun; 17():532-544. PubMed ID: 32258216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficiency modifications of SIV-based integrase-defective lentiviral vectors for immunization.
    Bona R; Michelini Z; Mazzei C; Gallinaro A; Canitano A; Borghi M; Vescio MF; Di Virgilio A; Pirillo MF; Klotman ME; Negri D; Cara A
    Mol Ther Methods Clin Dev; 2021 Dec; 23():263-275. PubMed ID: 34729374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lentiviral transduction of human hematopoietic cells by HIV-1- and SIV-based vectors containing a bicistronic cassette driven by various internal promoters.
    Dupuy FP; Mouly E; Mesel-Lemoine M; Morel C; Abriol J; Cherai M; Baillou C; Nègre D; Cosset FL; Klatzmann D; Lemoine FM
    J Gene Med; 2005 Sep; 7(9):1158-71. PubMed ID: 15880619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunization with an SIV-based IDLV Expressing HIV-1 Env 1086 Clade C Elicits Durable Humoral and Cellular Responses in Rhesus Macaques.
    Negri D; Blasi M; LaBranche C; Parks R; Balachandran H; Lifton M; Shen X; Denny T; Ferrari G; Vescio MF; Andersen H; Montefiori DC; Tomaras GD; Liao HX; Santra S; Haynes BF; Klotman ME; Cara A
    Mol Ther; 2016 Nov; 24(11):2021-2032. PubMed ID: 27455880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrase-deficient lentiviral vectors mediate efficient gene transfer to human vascular smooth muscle cells with minimal genotoxic risk.
    Chick HE; Nowrouzi A; Fronza R; McDonald RA; Kane NM; Alba R; Delles C; Sessa WC; Schmidt M; Thrasher AJ; Baker AH
    Hum Gene Ther; 2012 Dec; 23(12):1247-57. PubMed ID: 22931362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimization of mucosal responses after intramuscular immunization with integrase defective lentiviral vector.
    Rossi A; Michelini Z; Leone P; Borghi M; Blasi M; Bona R; Spada M; Grasso F; Gugliotta A; Klotman ME; Cara A; Negri D
    PLoS One; 2014; 9(9):e107377. PubMed ID: 25210766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An HIV-based lentiviral vector as HIV vaccine candidate: Immunogenic characterization.
    Lemiale F; Asefa B; Ye D; Chen C; Korokhov N; Humeau L
    Vaccine; 2010 Feb; 28(8):1952-61. PubMed ID: 20188251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different configurations of SARS-CoV-2 spike protein delivered by integrase-defective lentiviral vectors induce persistent functional immune responses, characterized by distinct immunogenicity profiles.
    Borghi M; Gallinaro A; Pirillo MF; Canitano A; Michelini Z; De Angelis ML; Cecchetti S; Tinari A; Falce C; Mariotti S; Capocefalo A; Chiantore MV; Iacobino A; Di Virgilio A; van Gils MJ; Sanders RW; Lo Presti A; Nisini R; Negri D; Cara A
    Front Immunol; 2023; 14():1147953. PubMed ID: 37090707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hybrid lentivirus-transposon vectors with a random integration profile in human cells.
    Staunstrup NH; Moldt B; Mátés L; Villesen P; Jakobsen M; Ivics Z; Izsvák Z; Mikkelsen JG
    Mol Ther; 2009 Jul; 17(7):1205-14. PubMed ID: 19240688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mucosal immunization with integrase-defective lentiviral vectors protects against influenza virus challenge in mice.
    Fontana JM; Christos PJ; Michelini Z; Negri D; Cara A; Salvatore M
    PLoS One; 2014; 9(5):e97270. PubMed ID: 24824623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High levels of transgene expression following transduction of long-term NOD/SCID-repopulating human cells with a modified lentiviral vector.
    Gao Z; Golob J; Tanavde VM; Civin CI; Hawley RG; Cheng L
    Stem Cells; 2001; 19(3):247-59. PubMed ID: 11359950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toward integrase defective lentiviral vectors for genetic immunization.
    Negri DR; Michelini Z; Cara A
    Curr HIV Res; 2010 Jun; 8(4):274-81. PubMed ID: 20353396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.